Voluntary Acetaminophen Labeling Revisions Include Overdose Warning
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer & Specialty Pharmaceuticals and Bayer Consumer Care are revising acetaminophen product labeling to add a distinct "overdose warning," the companies say in materials submitted to FDA's Nonprescription Drugs Advisory Committee
You may also be interested in...
FDA, NCL Launch “Take With Care” OTC Analgesic Safety Campaign
FDA is "very seriously" looking into labeling changes for OTC pain relievers, according to outgoing Associate Commissioner for External Relations Peter Pitts
McNeil Single-Active Children’s Cough/Cold OTCs Stress Simplicity, Safety
Simply Stuffy and Simply Cough cold medicines - "from the makers of Children's Tylenol" - are designed to reduce consumer confusion and alleviate pediatricians' concerns about unnecessarily medicating children, McNeil Consumer & Specialty Pharmaceuticals maintained
Acetaminophen “Black Box” Warning Would “Scare” Users, NDAC Rep Says
Use of a "black box" warning on OTC acetaminophen labeling would be an inappropriate means for alerting consumers about potential liver damage, two consultants to FDA's Nonprescription Drugs Advisory Committee said Sept. 19